MYUNGMOON Pharm co.,Ltd (017180.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

23.9x

Market Cap

KRW 42.44B

MomentumView details →

1D Return

−1.42%

YTD Return

−32.76%

RSI (14)

53.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

23.9x

Market Cap

KRW 42.44B

RSI (14)

53.5

MomentumView details →

1D Return

−1.42%

YTD Return

−32.76%

ProfitabilityView details →

Gross Margin

57.27%

Net Margin

−0.83%

EBITDA Margin

2.31%

ROE (TTM)

−1.71%

ROA (TTM)

−0.56%

Asset Turnover

0.70x

GrowthView details →

Revenue YoY

+4.75%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+8.67%

EPS CAGR 3Y

−37.54%

EBITDA YoY

−86.64%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.89x

Current Ratio

1.06x

Quick Ratio

0.67x

Div Yield

—

Div Rate

—

Div Growth 1Y

+107.10%

Financials snapshotView financials →

Revenue (TTM)

199.82B

Net Income (TTM)

−1.67B

Op. CF (TTM)

−3.55B

Latest newsMore news →

No recent news for 017180.KS.

Similar companies

Teva Pharmaceutical Industries LimitedTEVA Haleon plcHLN Shanghai Fosun Pharmaceutical (Group) Co., Ltd.02196.HK 白云山600332.SH Zoetis Inc.ZTS Yuyu Pharma, Inc.000225.KS Find similar companies →

Latest newsMore news →

No recent news for 017180.KS.